| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.34 | 6e-12 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-11 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.32 | 2e-10 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-10 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.31 | 4e-10 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.31 | 8e-10 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-09 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-09 |